Amid rising tensions between United States and Iran, a potential US invasion scenario outlines a three-phase military strategy. Phase one focuses on achieving air and missile dominance through ...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced first-patient-in for a Phase 1 clinical ...

Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue to improve to Week 40, with 62% of patients treated ...

If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kd) syndrome (APDS), a rare primary immunodeficiency ...

Virgin Galactic Holdings is a high-risk, high-reward play on commercial space travel, currently priced for failure. Click ...

How does the brain clean itself during sleep? A new ultrafast MRI method tracks cerebrospinal fluid flow without contrast ...

San Joaquin County officials submitted nearly $19 million in funding requests to federal lawmakers this week for 10 projects ...

She was one of a number of female “computers” at the observatory, whose job it was to process astronomical data. At this ...

Sky This Week is brought to you in part by Celestron. Friday, March 27The Moon passes through the outskirts of the famous ...

Delta’s partnership with Amazon’s low-Earth-orbit satellite network promises significantly faster in-flight internet.

If you thought the deals were winding down on day 6 of the Big Spring Sale, think again, as we have a bunch Green Deals ...

The EMA's human medicines committee has recommended approval of Amgen's bispecific T-cell engager (BiTE) – Imdylltra – as a second-line treatment option for extensive-stage small cell lung cancer ...